The United Nations Children’s Fund (UNICEF) has delivered 100,000 doses of Janssen (Jcovden) COVID-19 vector vaccine to Ukraine as part of the international COVAX initiative.
In August this year, Ukraine has already received the first batch of 100,000 doses of Janssen (Jcovden) vaccine.
Over the past week, more than 4,800 new cases of COVID-19 were recorded in Ukraine and more than 2,500 people were hospitalized. Vaccination is the only way to protect oneself from severe course of and death from coronavirus disease.
Janssen is a vector vaccine developed by Janssen, which is owned by Johnson & Johnson. Its trade name is Jcovden. The vaccine is intended for people aged 18 years and older. In Ukraine, one dose is administered for primary immunization, then booster vaccinations are required.
Since the beginning of the full-scale war, Ukraine has been receiving vaccines against coronavirus disease within the COVAX initiative only, free of charge. The COVAX initiative aims to ensure fair and equitable access to COVID-19 vaccines for every country in the world.
COVAX is coordinated by the Global Alliance for Vaccines and Immunization (GAVI), WHO and the Coalition for Epidemic Preparedness Innovation (CEPI), and UNICEF works with manufacturers and partners to procure and logistically deliver COVID-19 vaccines. COVAX works with civil society organizations, vaccine manufacturers, governments of the United States, the United Kingdom, the European Union, the World Bank and others.
WHO, UNICEF, GAVI, EU, UK, USAID continue to support Ukraine in vaccination against COVID-19 as part of the response to the COVID-19 pandemic during the war and humanitarian emergency. Thanks to COVAX supplies, Ukrainians will be able to further receive protection against coronavirus disease.
The delivery of the Janssen (Jcovden) vaccine was made possible thanks to the financial support of the United Kingdom.